Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ubiquitin-Protein Ligases | 28 | 2024 | 1861 | 3.110 |
Why?
|
Thalidomide | 12 | 2024 | 890 | 2.010 |
Why?
|
Peptide Hydrolases | 7 | 2018 | 634 | 1.470 |
Why?
|
Small Molecule Libraries | 8 | 2021 | 720 | 1.110 |
Why?
|
Ikaros Transcription Factor | 7 | 2022 | 217 | 1.110 |
Why?
|
Transcription Factors | 16 | 2024 | 12208 | 0.940 |
Why?
|
Ubiquitination | 16 | 2024 | 1012 | 0.910 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2023 | 215 | 0.820 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2023 | 1157 | 0.760 |
Why?
|
Adaptor Proteins, Signal Transducing | 13 | 2022 | 2916 | 0.740 |
Why?
|
Substrate Specificity | 8 | 2023 | 1801 | 0.710 |
Why?
|
Caspases | 1 | 2023 | 928 | 0.700 |
Why?
|
Proteomics | 9 | 2024 | 3638 | 0.650 |
Why?
|
Protein Kinase Inhibitors | 13 | 2023 | 5535 | 0.640 |
Why?
|
Drug Design | 4 | 2021 | 1076 | 0.630 |
Why?
|
Drug Discovery | 3 | 2021 | 1058 | 0.620 |
Why?
|
Duane Retraction Syndrome | 1 | 2018 | 60 | 0.620 |
Why?
|
Structure-Activity Relationship | 8 | 2023 | 3129 | 0.600 |
Why?
|
Cryoelectron Microscopy | 6 | 2024 | 571 | 0.580 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 996 | 0.570 |
Why?
|
Histone Deacetylases | 1 | 2021 | 728 | 0.560 |
Why?
|
Acetamides | 1 | 2018 | 249 | 0.560 |
Why?
|
Proteins | 4 | 2023 | 6103 | 0.540 |
Why?
|
Cell Cycle Proteins | 4 | 2021 | 3462 | 0.520 |
Why?
|
Proteome | 3 | 2022 | 1799 | 0.510 |
Why?
|
Polymers | 1 | 2022 | 1621 | 0.500 |
Why?
|
Immunologic Factors | 2 | 2022 | 1580 | 0.490 |
Why?
|
Tumor Suppressor Proteins | 4 | 2024 | 2849 | 0.460 |
Why?
|
Thiophenes | 1 | 2018 | 588 | 0.460 |
Why?
|
Protein Kinases | 1 | 2020 | 1640 | 0.460 |
Why?
|
Crystallography, X-Ray | 10 | 2021 | 2011 | 0.450 |
Why?
|
Sulfonamides | 2 | 2020 | 1938 | 0.450 |
Why?
|
Models, Molecular | 10 | 2021 | 5456 | 0.440 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2019 | 2915 | 0.440 |
Why?
|
Peptide Termination Factors | 2 | 2022 | 55 | 0.400 |
Why?
|
Ubiquitin | 3 | 2023 | 852 | 0.400 |
Why?
|
Indoles | 1 | 2019 | 1839 | 0.390 |
Why?
|
Molecular Structure | 5 | 2021 | 1899 | 0.390 |
Why?
|
Protein Binding | 12 | 2023 | 9386 | 0.380 |
Why?
|
Polymerization | 2 | 2022 | 164 | 0.380 |
Why?
|
Antibodies, Viral | 4 | 2023 | 3176 | 0.370 |
Why?
|
Apoptosis | 7 | 2024 | 9727 | 0.370 |
Why?
|
Biocatalysis | 3 | 2023 | 167 | 0.370 |
Why?
|
DNA-Binding Proteins | 7 | 2021 | 9648 | 0.370 |
Why?
|
Lymphoma, T-Cell | 2 | 2023 | 299 | 0.360 |
Why?
|
Drug Resistance, Neoplasm | 8 | 2023 | 5172 | 0.360 |
Why?
|
Ligands | 8 | 2023 | 3282 | 0.350 |
Why?
|
Cell Line | 8 | 2024 | 15997 | 0.350 |
Why?
|
Cyclins | 2 | 2023 | 603 | 0.350 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2021 | 290 | 0.350 |
Why?
|
Casein Kinase Ialpha | 2 | 2021 | 27 | 0.350 |
Why?
|
Methyltransferases | 2 | 2023 | 367 | 0.340 |
Why?
|
Fluorescence Resonance Energy Transfer | 2 | 2023 | 401 | 0.340 |
Why?
|
Zinc Fingers | 2 | 2024 | 585 | 0.330 |
Why?
|
Cell Line, Tumor | 23 | 2021 | 16689 | 0.320 |
Why?
|
Nuclear Proteins | 4 | 2022 | 5853 | 0.320 |
Why?
|
Antineoplastic Agents | 11 | 2023 | 13695 | 0.320 |
Why?
|
HEK293 Cells | 5 | 2021 | 4204 | 0.310 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 2988 | 0.300 |
Why?
|
Kinetics | 5 | 2021 | 6473 | 0.290 |
Why?
|
Phthalimides | 2 | 2024 | 25 | 0.280 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2019 | 322 | 0.280 |
Why?
|
Multiprotein Complexes | 4 | 2020 | 1119 | 0.270 |
Why?
|
Amino Acid Motifs | 2 | 2019 | 936 | 0.270 |
Why?
|
Multiple Myeloma | 5 | 2022 | 5181 | 0.260 |
Why?
|
Humans | 73 | 2024 | 744343 | 0.250 |
Why?
|
Neoplasms | 6 | 2024 | 21683 | 0.250 |
Why?
|
Binding Sites | 8 | 2023 | 6114 | 0.250 |
Why?
|
Leukemia | 2 | 2023 | 1511 | 0.240 |
Why?
|
Piperidones | 1 | 2024 | 28 | 0.240 |
Why?
|
Enzyme Activation | 3 | 2023 | 3701 | 0.230 |
Why?
|
Factor V | 1 | 2024 | 178 | 0.230 |
Why?
|
Dibenzazepines | 1 | 2022 | 26 | 0.220 |
Why?
|
RNA, Transfer | 2 | 2023 | 316 | 0.220 |
Why?
|
Cell Nucleus | 3 | 2023 | 2969 | 0.220 |
Why?
|
Nucleocapsid | 1 | 2023 | 59 | 0.220 |
Why?
|
Piperazines | 4 | 2021 | 2488 | 0.220 |
Why?
|
Directed Molecular Evolution | 1 | 2024 | 160 | 0.220 |
Why?
|
Cytokine Receptor Common beta Subunit | 1 | 2022 | 22 | 0.220 |
Why?
|
RNA Processing, Post-Transcriptional | 2 | 2023 | 436 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2022 | 66 | 0.210 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2021 | 29 | 0.210 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2021 | 55 | 0.210 |
Why?
|
Cyclin-Dependent Kinase 9 | 2 | 2021 | 66 | 0.200 |
Why?
|
DNA Damage | 5 | 2019 | 2432 | 0.200 |
Why?
|
tRNA Methyltransferases | 1 | 2021 | 53 | 0.200 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4560 | 0.200 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 294 | 0.200 |
Why?
|
Methanol | 1 | 2021 | 85 | 0.200 |
Why?
|
Carrier Proteins | 4 | 2023 | 5021 | 0.200 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2021 | 105 | 0.190 |
Why?
|
Chimera | 1 | 2022 | 485 | 0.190 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2021 | 215 | 0.190 |
Why?
|
Morpholines | 1 | 2024 | 571 | 0.190 |
Why?
|
Pyrrolidines | 1 | 2022 | 342 | 0.190 |
Why?
|
Indoleacetic Acids | 1 | 2020 | 44 | 0.190 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2021 | 107 | 0.190 |
Why?
|
Pyridines | 3 | 2021 | 2825 | 0.190 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2021 | 234 | 0.190 |
Why?
|
Eukaryota | 1 | 2021 | 99 | 0.190 |
Why?
|
Molecular Conformation | 2 | 2019 | 563 | 0.180 |
Why?
|
Oncogenes | 2 | 2023 | 1265 | 0.180 |
Why?
|
Cell Proliferation | 9 | 2023 | 10481 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 193 | 0.180 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 188 | 0.180 |
Why?
|
RNA-Binding Protein EWS | 1 | 2021 | 216 | 0.180 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2020 | 1338 | 0.180 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 250 | 0.180 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2020 | 191 | 0.180 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2020 | 112 | 0.180 |
Why?
|
Spodoptera | 1 | 2019 | 153 | 0.180 |
Why?
|
Oncogene Proteins | 2 | 2021 | 749 | 0.180 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2022 | 377 | 0.170 |
Why?
|
Cross Reactions | 1 | 2021 | 841 | 0.170 |
Why?
|
Jurkat Cells | 1 | 2021 | 743 | 0.170 |
Why?
|
HCT116 Cells | 2 | 2017 | 408 | 0.170 |
Why?
|
Chromatin | 4 | 2023 | 2934 | 0.170 |
Why?
|
Inflammasomes | 1 | 2024 | 495 | 0.170 |
Why?
|
Lower Extremity Deformities, Congenital | 1 | 2018 | 12 | 0.170 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2024 | 1285 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2019 | 538 | 0.160 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2024 | 3523 | 0.160 |
Why?
|
Databases, Protein | 1 | 2020 | 383 | 0.160 |
Why?
|
Upper Extremity Deformities, Congenital | 1 | 2018 | 29 | 0.160 |
Why?
|
Protein Phosphatase 2 | 1 | 2020 | 229 | 0.160 |
Why?
|
GTP-Binding Proteins | 1 | 2023 | 970 | 0.160 |
Why?
|
Mutation | 8 | 2024 | 29786 | 0.160 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2021 | 507 | 0.160 |
Why?
|
Lysine | 1 | 2022 | 1007 | 0.160 |
Why?
|
Teratogens | 1 | 2018 | 112 | 0.160 |
Why?
|
Animals | 17 | 2024 | 168757 | 0.150 |
Why?
|
Immunologic Surveillance | 1 | 2018 | 93 | 0.150 |
Why?
|
Viral Nonstructural Proteins | 1 | 2019 | 241 | 0.150 |
Why?
|
Xenopus | 1 | 2019 | 712 | 0.150 |
Why?
|
Phosphorylation | 7 | 2023 | 8436 | 0.150 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2021 | 10943 | 0.150 |
Why?
|
Cullin Proteins | 3 | 2016 | 180 | 0.150 |
Why?
|
Pyrimidinones | 1 | 2019 | 371 | 0.150 |
Why?
|
Species Specificity | 2 | 2018 | 2478 | 0.150 |
Why?
|
Immunity, Humoral | 1 | 2021 | 598 | 0.150 |
Why?
|
Mammals | 1 | 2022 | 1143 | 0.150 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2023 | 1581 | 0.140 |
Why?
|
Purines | 1 | 2020 | 594 | 0.140 |
Why?
|
Lymphoma, B-Cell | 1 | 2023 | 931 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 1 | 2024 | 1836 | 0.140 |
Why?
|
Biphenyl Compounds | 1 | 2021 | 913 | 0.140 |
Why?
|
Isoenzymes | 1 | 2021 | 1726 | 0.140 |
Why?
|
Nucleotidyltransferases | 1 | 2018 | 220 | 0.140 |
Why?
|
Tubulin | 1 | 2020 | 695 | 0.140 |
Why?
|
Protein Structure, Secondary | 1 | 2019 | 1246 | 0.140 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2018 | 233 | 0.140 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 789 | 0.140 |
Why?
|
Signal Transduction | 8 | 2023 | 23403 | 0.140 |
Why?
|
Frontotemporal Dementia | 1 | 2019 | 248 | 0.130 |
Why?
|
Catalytic Domain | 4 | 2023 | 698 | 0.130 |
Why?
|
Protein Interaction Mapping | 1 | 2019 | 627 | 0.130 |
Why?
|
Acrylamides | 1 | 2017 | 255 | 0.130 |
Why?
|
Pyrazines | 1 | 2021 | 1230 | 0.130 |
Why?
|
Protease Inhibitors | 1 | 2019 | 791 | 0.130 |
Why?
|
Tauopathies | 1 | 2019 | 307 | 0.130 |
Why?
|
Mice | 12 | 2024 | 81183 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2024 | 2503 | 0.130 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2018 | 478 | 0.130 |
Why?
|
Lysosomes | 1 | 2020 | 893 | 0.130 |
Why?
|
Ubiquitins | 3 | 2023 | 384 | 0.130 |
Why?
|
Autophagy | 1 | 2023 | 1300 | 0.130 |
Why?
|
Quinazolines | 2 | 2021 | 1356 | 0.120 |
Why?
|
Cell Survival | 3 | 2021 | 5882 | 0.120 |
Why?
|
Principal Component Analysis | 1 | 2017 | 940 | 0.120 |
Why?
|
Drug Resistance, Viral | 1 | 2019 | 820 | 0.120 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2017 | 491 | 0.120 |
Why?
|
Benzamides | 1 | 2019 | 1379 | 0.120 |
Why?
|
Stress, Physiological | 1 | 2021 | 1403 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 1222 | 0.110 |
Why?
|
Pyrimidines | 3 | 2019 | 2942 | 0.110 |
Why?
|
GTP Phosphohydrolases | 1 | 2016 | 509 | 0.110 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2023 | 182 | 0.110 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2021 | 1052 | 0.110 |
Why?
|
Xeroderma Pigmentosum Group A Protein | 1 | 2011 | 13 | 0.110 |
Why?
|
Neuroprotective Agents | 1 | 2019 | 941 | 0.100 |
Why?
|
Pyrazoles | 2 | 2019 | 1972 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1692 | 0.100 |
Why?
|
ras Proteins | 1 | 2017 | 1060 | 0.100 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2016 | 581 | 0.100 |
Why?
|
Hormones | 1 | 2016 | 889 | 0.100 |
Why?
|
Abnormalities, Multiple | 1 | 2018 | 1416 | 0.090 |
Why?
|
Embryonic Stem Cells | 1 | 2018 | 1294 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 1903 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 1 | 2023 | 4554 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2019 | 2455 | 0.090 |
Why?
|
Ultraviolet Rays | 2 | 2015 | 1060 | 0.090 |
Why?
|
Protein Stability | 2 | 2022 | 557 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2203 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2022 | 3479 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3798 | 0.090 |
Why?
|
tau Proteins | 1 | 2019 | 1868 | 0.090 |
Why?
|
Gene Deletion | 1 | 2017 | 2751 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2529 | 0.080 |
Why?
|
RNA, Messenger | 2 | 2021 | 13033 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4462 | 0.080 |
Why?
|
DNA Repair | 2 | 2023 | 2046 | 0.080 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13102 | 0.080 |
Why?
|
Myelodysplastic Syndromes | 1 | 2017 | 1352 | 0.070 |
Why?
|
Allosteric Regulation | 2 | 2020 | 408 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2019 | 2987 | 0.070 |
Why?
|
Amino Acid Sequence | 1 | 2018 | 13815 | 0.070 |
Why?
|
Protein Structure, Tertiary | 3 | 2018 | 3846 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2024 | 20822 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8388 | 0.060 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2421 | 0.060 |
Why?
|
Cells, Cultured | 1 | 2020 | 19229 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2018 | 1723 | 0.060 |
Why?
|
DNA | 1 | 2018 | 7301 | 0.060 |
Why?
|
Mitogens | 1 | 2024 | 232 | 0.060 |
Why?
|
Co-Repressor Proteins | 1 | 2023 | 194 | 0.050 |
Why?
|
Allosteric Site | 1 | 2022 | 103 | 0.050 |
Why?
|
Protein Conformation | 2 | 2022 | 4011 | 0.050 |
Why?
|
Coronavirus OC43, Human | 1 | 2021 | 18 | 0.050 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2024 | 452 | 0.050 |
Why?
|
Interleukin-5 | 1 | 2022 | 273 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6314 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2018 | 4584 | 0.050 |
Why?
|
Guanosine | 1 | 2021 | 61 | 0.050 |
Why?
|
Interleukin-3 | 1 | 2022 | 444 | 0.050 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
Immunologic Tests | 1 | 2021 | 103 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2024 | 648 | 0.050 |
Why?
|
Erythroid Cells | 1 | 2022 | 238 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 697 | 0.050 |
Why?
|
Trans-Activators | 2 | 2021 | 2924 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.050 |
Why?
|
Female | 8 | 2024 | 380194 | 0.050 |
Why?
|
Phenothiazines | 1 | 2020 | 63 | 0.050 |
Why?
|
Young Adult | 3 | 2021 | 56430 | 0.050 |
Why?
|
Enzyme Activators | 1 | 2020 | 57 | 0.050 |
Why?
|
Hydrogen Bonding | 1 | 2020 | 293 | 0.050 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 128 | 0.050 |
Why?
|
Dipeptides | 1 | 2022 | 409 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19905 | 0.050 |
Why?
|
Benzylamines | 1 | 2021 | 223 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2021 | 6622 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 291 | 0.040 |
Why?
|
Imides | 1 | 2019 | 15 | 0.040 |
Why?
|
Solvents | 1 | 2020 | 302 | 0.040 |
Why?
|
Neurons | 1 | 2019 | 9338 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2024 | 635 | 0.040 |
Why?
|
Adolescent | 3 | 2022 | 85781 | 0.040 |
Why?
|
Models, Immunological | 1 | 2021 | 527 | 0.040 |
Why?
|
Prodrugs | 1 | 2021 | 268 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 903 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 551 | 0.040 |
Why?
|
G1 Phase | 1 | 2020 | 415 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 871 | 0.040 |
Why?
|
Aminopyridines | 1 | 2022 | 542 | 0.040 |
Why?
|
Synthetic Biology | 1 | 2020 | 179 | 0.040 |
Why?
|
Serine | 1 | 2022 | 826 | 0.040 |
Why?
|
Methylation | 1 | 2021 | 1106 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 809 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2024 | 972 | 0.040 |
Why?
|
Cytoplasm | 1 | 2022 | 1539 | 0.040 |
Why?
|
Protein Transport | 1 | 2024 | 1988 | 0.040 |
Why?
|
Nucleotides, Cyclic | 1 | 2018 | 81 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2021 | 541 | 0.040 |
Why?
|
Genome, Human | 1 | 2011 | 4420 | 0.040 |
Why?
|
Benzofurans | 1 | 2018 | 140 | 0.040 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2018 | 195 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 730 | 0.040 |
Why?
|
Gene Expression | 2 | 2022 | 7799 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 992 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 363 | 0.040 |
Why?
|
Carrier State | 1 | 2021 | 518 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1783 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2017 | 459 | 0.040 |
Why?
|
Cell Death | 1 | 2022 | 1706 | 0.040 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2020 | 671 | 0.040 |
Why?
|
Oxazoles | 1 | 2017 | 189 | 0.040 |
Why?
|
Protein Subunits | 1 | 2020 | 959 | 0.040 |
Why?
|
Apoproteins | 1 | 2016 | 44 | 0.040 |
Why?
|
Protein Engineering | 1 | 2020 | 540 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2021 | 847 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2022 | 1607 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1152 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 612 | 0.030 |
Why?
|
Sulfones | 1 | 2018 | 437 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2022 | 1904 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1660 | 0.030 |
Why?
|
Chemotaxis | 1 | 2018 | 607 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2022 | 1676 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1114 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1012 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2017 | 413 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1990 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1655 | 0.030 |
Why?
|
Amides | 1 | 2017 | 459 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1878 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3271 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2540 | 0.030 |
Why?
|
Oligopeptides | 1 | 2019 | 1189 | 0.030 |
Why?
|
Adenine | 1 | 2018 | 936 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2716 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2018 | 970 | 0.030 |
Why?
|
Cell Division | 1 | 2020 | 4568 | 0.030 |
Why?
|
Vibrio cholerae | 1 | 2018 | 806 | 0.030 |
Why?
|
Hepacivirus | 1 | 2019 | 1379 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.020 |
Why?
|
Survivors | 1 | 2021 | 2291 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 3023 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
Thiazoles | 1 | 2017 | 1483 | 0.020 |
Why?
|
Piperidines | 1 | 2018 | 1602 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1708 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2017 | 1526 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 213383 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2022 | 3386 | 0.020 |
Why?
|
Adult | 2 | 2021 | 214055 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9687 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2011 | 349 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5655 | 0.020 |
Why?
|
Hepatitis C | 1 | 2019 | 1591 | 0.020 |
Why?
|
Male | 3 | 2021 | 350118 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40561 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3589 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4445 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10180 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13284 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5720 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8428 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18029 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4838 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10638 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12261 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3494 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 25625 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5221 | 0.010 |
Why?
|
Infant | 1 | 2021 | 35136 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 41006 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53288 | 0.010 |
Why?
|
Child | 1 | 2021 | 77709 | 0.010 |
Why?
|
Aged | 1 | 2021 | 163280 | 0.010 |
Why?
|